Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Moodys
Dow
Baxter
Boehringer Ingelheim
Harvard Business School
AstraZeneca

Last Updated: August 17, 2022

Investigational Drug Information for Methylthioninium


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the drug development status for Methylthioninium?

Methylthioninium is an investigational drug.

There have been 8 clinical trials for Methylthioninium. The most recent clinical trial was a Phase 3 trial, which was initiated on March 31st 2018.

The most common disease conditions in clinical trials are Carcinoma, Squamous Cell, Dementia, and Mucositis. The leading clinical trial sponsors are Fundação Educacional Serra dos Órgãos, M.D. Anderson Cancer Center, and Prokhorov General Physics Institute of the Russian Academy of Sciences (GPI RAS).

There are thirty-three US patents protecting this investigational drug and three international patents.

Recent Clinical Trials for Methylthioninium
TitleSponsorPhase
COVID-19 Treatment Using Methylene Blue and Photodynamic TherapyProkhorov General Physics Institute of the Russian Academy of Sciences (GPI RAS)Phase 1
COVID-19 Treatment Using Methylene Blue and Photodynamic TherapyI.M. Sechenov First Moscow State Medical UniversityPhase 1
MOM's PAIN (Methylene Blue for Oral Mucositis' PAIN)M.D. Anderson Cancer CenterPhase 2

See all Methylthioninium clinical trials

Clinical Trial Summary for Methylthioninium

Top disease conditions for Methylthioninium
Top clinical trial sponsors for Methylthioninium

See all Methylthioninium clinical trials

US Patents for Methylthioninium

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Methylthioninium See Plans and Pricing Multimodal silica-based nanoparticles See Plans and Pricing
Methylthioninium See Plans and Pricing Up and down conversion systems for production of emitted light from various energy sources including radio frequency, microwave energy and magnetic induction sources for upconversion IMMUNOLIGHT, LLC (Detroit, MI) DUKE UNIVERSITY (Durham, NC) See Plans and Pricing
Methylthioninium See Plans and Pricing Compostions and methods for diagnosis of axial pain with or without radiculopathy Warsaw Orthopedic, Inc. (Warsaw, IN) See Plans and Pricing
Methylthioninium See Plans and Pricing Screening method Iomet Pharma Ltd. (Midlothian, GB) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Methylthioninium

Drugname Country Document Number Estimated Expiration Related US Patent
Methylthioninium Australia AU2013240312 2032-03-30 See Plans and Pricing
Methylthioninium Australia AU2013326904 2032-03-30 See Plans and Pricing
Methylthioninium Australia AU2014238036 2032-03-30 See Plans and Pricing
Methylthioninium Australia AU2018241060 2032-03-30 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Dow
Baxter
Boehringer Ingelheim
Harvard Business School
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.